Orchestra BioMed Holdings, Inc. Payments of Merger Related Costs, Financing Activities
Orchestra BioMed Holdings, Inc. (OBIO) reported Payments of Merger Related Costs, Financing Activities of $2.73 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2023-08-10
- Orchestra BioMed Holdings, Inc. payments of merger related costs, financing activities for the quarter ending 2022-06-30 was $1.12M.
- Orchestra BioMed Holdings, Inc. payments of merger related costs, financing activities for the quarter ending 2022-03-31 was $1.61M.
| Period end | Payments of Merger Related Costs, Financing Activities 3 month | Payments of Merger Related Costs, Financing Activities 6 month |
|---|---|---|
| 2022-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.73M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $1.61M 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |